Welcome to LookChem.com Sign In|Join Free
  • or
4-(4-Formylphenoxy)benzoic acid, an aromatic compound with the molecular formula C14H10O4, is characterized by a benzene ring substituted with a formyl group and a phenoxy group. It is a versatile building block in the synthesis of various organic compounds and has potential applications in the development of new materials and pharmaceuticals. Its unique chemical structure also makes it a valuable tool for studying organic chemical reactions and mechanisms.

2509-18-4

Post Buying Request

2509-18-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2509-18-4 Usage

Uses

Used in Research and Pharmaceutical Applications:
4-(4-Formylphenoxy)benzoic acid is used as a building block for the synthesis of various organic compounds, contributing to the development of new materials and pharmaceuticals.
Used in the Production of Dyes and Pigments:
4-(4-Formylphenoxy)benzoic acid is used as a key component in the production of dyes and pigments, enhancing their color properties and performance.
Used in Specialty Chemicals Industry:
4-(4-Formylphenoxy)benzoic acid is utilized in the production of specialty chemicals, where its unique structure and properties contribute to the development of innovative products.
Used in Organic Chemical Reactions and Mechanisms Study:
4-(4-Formylphenoxy)benzoic acid serves as a valuable tool for studying organic chemical reactions and mechanisms, providing insights into the behavior of similar compounds and advancing the understanding of organic chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 2509-18-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,0 and 9 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2509-18:
(6*2)+(5*5)+(4*0)+(3*9)+(2*1)+(1*8)=74
74 % 10 = 4
So 2509-18-4 is a valid CAS Registry Number.

2509-18-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-FORMYLPHENOXY)BENZOIC ACID

1.2 Other means of identification

Product number -
Other names 4-(4-Formyl-phenoxy)-benzoesaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2509-18-4 SDS

2509-18-4Relevant academic research and scientific papers

Discovery of orally available spirodiketopiperazine-based CCR5 antagonists

Nishizawa, Rena,Nishiyama, Toshihiko,Hisaichi, Katsuya,Hirai, Keisuke,Habashita, Hiromu,Takaoka, Yoshikazu,Tada, Hideaki,Sagawa, Kenji,Shibayama, Shiro,Maeda, Kenji,Mitsuya, Hiroaki,Nakai, Hisao,Fukushima, Daikichi,Toda, Masaaki

experimental part, p. 5208 - 5223 (2010/09/18)

Using the previously reported novel spirodiketopiperazine scaffold, the design and synthesis of orally available CCR5 antagonists was undertaken. Compounds possessing a carboxylic acid function in the appropriate position showed improved oral exposure (AU

PYRROLIDINE DERIVATIVE OR SALT THEREOF

-

Page/Page column 46-47, (2008/06/13)

[PROBLEMS] To provide a compound which can be used for the treatment of a disease associated with a calcium-sensing receptor (CaSR), particularly hyperparathyroidism. [MEANS FOR SOLVING PROBLEMS] It is found that a novel pyrrolidine derivative having an aminomethyl group substituted by an arylaklyl group or the like or a salt thereof has an excellent CaSR agonistic modulation effect and also has an excellent selectivity in the inhibition of CYP2D6 which may cause a drug-drug interaction. Thus, the novel pyrrolidine derivative is useful as a therapeutic agent for a disease associated with CaSR (e.g., hyperparathyroidism, renal osteodystrophy and hypercalcemia).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2509-18-4